Nanocarriers: more than tour de force for thymoquinone (2020)
Rathore, Charul; Rathbone, Michael J; Chellappan, Dinesh Kumar; Tambuwala, Murtaza M 
; Pinto, Terezinha de Jesus Andreoli ; Dureja, Harish; Hemrajani, Chetna; Gupta, Gaurav ; Dua, Kamal; Negi, Poonam
Source: Expert Opinion on Drug Delivery. Unidade: FCF
Subjects: NANOPARTÍCULAS, BIODISPONIBILIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RATHORE, Charul et al. Nanocarriers: more than tour de force for thymoquinone. Expert Opinion on Drug Delivery, v. 17, n. 4, p. 479-494, 2020Tradução . . Disponível em: https://doi.org/10.1080/17425247.2020.1730808. Acesso em: 21 maio 2024.APA
Rathore, C., Rathbone, M. J., Chellappan, D. K., Tambuwala, M. M., Pinto, T. de J. A., Dureja, H., et al. (2020). Nanocarriers: more than tour de force for thymoquinone. Expert Opinion on Drug Delivery, 17( 4), 479-494. doi:10.1080/17425247.2020.1730808NLM
Rathore C, Rathbone MJ, Chellappan DK, Tambuwala MM, Pinto T de JA, Dureja H, Hemrajani C, Gupta G, Dua K, Negi P. Nanocarriers: more than tour de force for thymoquinone [Internet]. Expert Opinion on Drug Delivery. 2020 ; 17( 4): 479-494.[citado 2024 maio 21 ] Available from: https://doi.org/10.1080/17425247.2020.1730808Vancouver
Rathore C, Rathbone MJ, Chellappan DK, Tambuwala MM, Pinto T de JA, Dureja H, Hemrajani C, Gupta G, Dua K, Negi P. Nanocarriers: more than tour de force for thymoquinone [Internet]. Expert Opinion on Drug Delivery. 2020 ; 17( 4): 479-494.[citado 2024 maio 21 ] Available from: https://doi.org/10.1080/17425247.2020.1730808
